Arizona Cypress Allergy Shots: The Southwest's Most Potent Cupressaceae
Arizona cypress allergy shots (SCIT) target the most diagnostically potent Cupressaceae extract in clinical use — 57% of cypress-allergic patients react to purified Cup a 1 per Alisi et al. (Allergy 2001), the highest single-component IgE-binding fraction documented for any Cupressaceae allergen. Cup a 1 shares >95% similarity with Jun a 1 (mountain cedar), making it the molecular bridge between the American Southwest and the entire global Cupressaceae family.
Arizona Cypress Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to arizona cypress — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of arizona cypress allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of arizona cypress immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of arizona cypress extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for arizona cypress allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing arizona cypress extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription arizona cypress immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat arizona cypress allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Arizona Cypress?
The biology, taxonomy, and clinical fingerprint of Arizona Cypress — the foundation of how SCIT targets it.
Hesperocyparis arizonica (Arizona cypress) releasing pollen in January–February in Phoenix. Cup a 1, its major allergen, is the most diagnostically reactive single Cupressaceae component identified to date.
- Scientific name
- Hesperocyparis arizonica (formerly Cupressus arizonica)
- Family
- CupressaceaeCypress family
- Type
- Mid-winter tree pollen
- Native to
- Southwestern United States (AZ, NM, west TX); widely planted as ornamental and windbreak across the desert Southwest
- Allergen proteins
- Cup a 1 (major) — pectate lyase, ~43 kDa; 57% of cypress-allergic patients react to purified Cup a 1 (Alisi et al., Allergy 2001;56:978–984); shares >75% sequence identity and >95% similarity with Jun a 1 (mountain cedar), Jun v 1 (red cedar), Cup s 1 (Mediterranean cypress), Cha o 1 (Japanese cypress), Cry j 1 (Japanese cedar) — Midoro-Horiuti 1999Cup a 3 — thaumatin-like protein; minor allergen with limited cross-reactivity with peach, tomato, apple, kiwi in sensitized subsets
- Particle size
- ~22 μm
- Avoidance difficulty
- Nearly impossible
How Arizona Cypress Allergy Presents
Symptoms by body system — useful for distinguishing Arizona Cypress sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and profuse rhinorrhea beginning in January in Phoenix and Tucson
- Sneezing episodes during outdoor exposure when cypress pollen is releasing
- Asthma exacerbations in sensitized patients during the January–February peak
- Postnasal drip and chronic cough overlapping with Arizona ash season
Ocular
- Bilateral allergic conjunctivitis during January–February cypress pollen peak
- Periorbital swelling on high-count days in Phoenix, Albuquerque, and Tucson
- Photophobia and persistent redness during peak release
Dermal
- Contact urticaria from handling Arizona cypress foliage or cones
- Generalized skin itching on high-pollen days in sensitized individuals
- Eczema flares in atopic patients during the January–February Cupressaceae peak
Systemic
- Fatigue from sustained winter allergy burden in Phoenix and the desert Southwest
- Sleep disruption from nocturnal nasal blockage during peak season
- Headache from sinus pressure on high pollen-count days
- Reduced quality of life during what is otherwise peak outdoor season in the Southwest
The Alisi 2001 finding — 57% of cypress-allergic patients react to purified Cup a 1 — makes Arizona cypress the single most diagnostically informative Cupressaceae component I use in a Phoenix or Albuquerque clinic. If a patient tests positive to Cup a 1, the cross-reactivity with mountain cedar, red cedar, and Japanese cedar is essentially guaranteed via the shared parallel beta-helical pectate-lyase core.
When & Where Arizona Cypress Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: January–February in Phoenix, Tucson, and Albuquerque; overlapping with tail end of mountain cedar season and Arizona ash season· ~8–10 weeks (January–February with a March tail); season shifts earlier with warming winters per Anderegg et al. PNAS 2021
US Exposure Map
2 high-intensity statesWhat Arizona Cypress Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Cup a 1 shares >75% sequence identity and >95% similarity with every major Cupressaceae pectate-lyase allergen — Jun a 1 (mountain cedar), Jun v 1 (red cedar), Cup s 1 (Mediterranean cypress), Cha o 1 (Japanese cypress), and Cry j 1 (Japanese cedar) — making Arizona cypress SCIT the cross-protection key for the entire global Cupressaceae family.
Cup a 1 / Jun a 1 >75% identity and >95% similarity — essentially the same protein (Midoro-Horiuti 1999)
Family-level cross-reactivity; Arizona cypress is typically prescribed separately from juniper-mix despite the same family
Cup a 1 / Jun v 1 same Cupressaceae pectate-lyase family; cross-protection essentially complete
Same Cupressaceae family; cross-reactivity by IgE inhibition documented (Ramirez & Lockey 2012)
Cup a 3 thaumatin-like cross-reactivity; limited OAS in sensitized subset only
Cypress-Fruit Syndrome (Thaumatin-Like Cross-Reactivity)
A small subset of Arizona cypress-sensitized patients with IgE to Cup a 3 (thaumatin-like minor allergen) may experience mild oral allergy syndrome with certain fruits. This affects a sensitized minority and typically causes only oral tingling rather than systemic symptoms.
Is SCIT Right for Your Arizona Cypress Allergy?
Answer five questions to assess whether Arizona cypress SCIT is right for your winter allergy profile.
How severe are your January–February allergy symptoms in the Southwest (Phoenix, Tucson, Albuquerque)?
The Arizona Cypress SCIT Protocol
Arizona cypress SCIT uses a non-standardized Cup a 1 extract. Build-up typically begins in August–September to reach maintenance before January cypress season. In Europe, Stallergènes produces a standardized cypress extract used in clinical studies — the closest evidence base for this protocol.
Incremental dose escalation from the most dilute vial. Your allergist may prescribe cypress separately from juniper-mix, as Arizona cypress (Hesperocyparis) is typically formulated independently from Juniperus species in practice. Each dose is followed by a 30-minute observation; with Curex, eligible patients run this same escalation at home and the first dose plus every dose increase are supervised live over Zoom.
Monthly maintenance injections sustain Cup a 1 tolerance. The >95% similarity with Jun a 1 (mountain cedar) means that Cup a 1-specific tolerance cross-protects the entire Cupressaceae pectate-lyase family simultaneously. EU small studies with standardized cypress extract show immunologic response consistent with the mountain-cedar literature. The 30-minute observation continues throughout.
After completing 3–5 years, your allergist assesses durable tolerance. European experience with standardized cypress extract suggests lasting benefit beyond the active treatment period.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Arizona Cypress SCIT
Arizona cypress SCIT is supported by EU small studies with standardized cypress extract and the molecular rationale of >95% Cup a 1 / Jun a 1 similarity. No US RCT specific to Arizona cypress exists as of 2025.
- Cup a 1 IgE reaction rate in cypress-allergic patients57%Alisi C, Afferni C, Iacovacci P, et al. Allergy 2001;56(10):978–984 — 57% of cypress-allergic patients react to purified Cup a 1; highest single-component Cupressaceae reaction rate documented
- Cup a 1 / Jun a 1 similarity (cross-protection basis)95%Midoro-Horiuti T et al., JACI 1999;104:608–617 — >95% similarity between Cup a 1 and Jun a 1; essentially equivalent proteins
- EU small studies with standardized cypress extract (Stallergènes)65%Multiple EU small studies using Stallergènes standardized cypress extract — clinical benefit demonstrated; no large RCT
- Mountain cedar observational SCIT benefit (cross-applies via Cup a 1 / Jun a 1 similarity)70%Goetz DW and Ramirez DA & Lockey RF, Ann Allergy Asthma Immunol 2012 — mountain-cedar evidence cross-applicable via >95% Cup a 1 / Jun a 1 similarity
No US randomized controlled trial specific to Arizona cypress SCIT exists as of 2025. The EU Stallergènes small studies with standardized cypress extract show clinical benefit, and the >95% Cup a 1 / Jun a 1 similarity makes the mountain-cedar observational and controlled literature directly applicable. Arizona cypress has the strongest diagnostic-reactivity evidence in the Cupressaceae family (Alisi 2001 — 57% Cup a 1 reaction rate), making it the most informative single component for Southwest Cupressaceae evaluation.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Arizona Cypress SCIT Side Effects
Arizona cypress SCIT carries the standard inhalant immunotherapy side-effect profile — local reactions are expected during build-up; serious systemic reactions are rare under proper protocols.
Local reactions
4 documentedSystemic reactions
4 documentedArizona cypress SCIT injections are administered in an allergy office with epinephrine and resuscitation equipment available. The mandatory 30-minute post-injection observation captures the vast majority of systemic reactions (Greenhawt et al., Ann Allergy Asthma Immunol 2023).
SCIT vs Alternatives for Arizona Cypress
Southwest patients with Arizona cypress allergy have four options: SCIT (EU small-study evidence via standardized cypress extract; mountain-cedar cross-protection rationale) — available as a weekly at-home shot with Curex — sublingual drops, avoidance, or daily antihistamines and nasal steroids.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | EU small studies with Stallergènes standardized extract; mountain-cedar evidence via >95% Cup a 1 / Jun a 1 similarity | Emerging evidence; Cup a 1-based drops show immunologic activity in EU studies | Difficult in Phoenix and Albuquerque with dense ornamental plantings | Good for mild-moderate winter AR; may be insufficient at peak pollen counts |
| 5-yr cost | $3,500–$15,000 over 5 years | $39–$150/month depending on provider | Low direct cost; high lifestyle burden | $300–$1,200/year for prescriptions |
| Duration | 3–5 years weekly then monthly | 3–5 years daily drops | Permanent lifestyle restriction during January–February | Lifelong seasonal use |
| Convenience | At-home weekly self-injection with Curex through the ~6-month build-up, then monthly; first dose and dose changes supervised live over Zoom | At-home; no clinic visits needed | HEPA filtration indoors helps; outdoor avoidance during Jan–Feb peak impractical | Convenient daily antihistamines and nasal steroids |
| Safety | Excellent; rare systemic reactions with observation | Lower systemic reaction risk than SCIT | No treatment risk; no disease modification | Well-established safety profile |
| Lasting effect | Years of lasting benefit after completing course | Duration of benefit still being studied | No lasting benefit; symptoms return every winter | No lasting benefit; symptoms return when medications stop |
SCITBest
SLIT
Avoidance
Medications
For Southwest patients with moderate-to-severe January–February cypress allergy, SCIT delivers Cupressaceae family-wide cross-protection via Cup a 1 — the most diagnostically potent Cupressaceae component (Alisi 2001) — and with Curex, eligible patients self-administer that shot at home for $129/month, with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand.
What Arizona Cypress SCIT Actually Costs
Most major US insurers cover Arizona cypress SCIT under standard allergy benefits when prescribed by a board-certified allergist in the Southwest. In Phoenix, Tucson, and Albuquerque, Arizona cypress is a well-recognized seasonal aeroallergen and coverage is generally available. Out-of-pocket cost depends on your plan's deductible and co-insurance. Curex at-home IgE testing identifies specific arizona cypress sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your arizona cypress allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Arizona Cypress SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Cup a 1 is the major allergen of Arizona cypress — a pectate lyase enzyme of ~43 kDa. Alisi et al. (Allergy 2001;56:978–984) demonstrated that 57% of cypress-allergic patients react to purified Cup a 1, the highest single-component IgE-binding fraction documented for any Cupressaceae allergen in head-to-head testing. Because Cup a 1 shares >75% sequence identity and >95% similarity with Jun a 1 (mountain cedar), Jun v 1 (red cedar), Cup s 1 (Mediterranean cypress), Cha o 1 (Japanese cypress), and Cry j 1 (Japanese cedar) per Midoro-Horiuti 1999, a positive Cup a 1 test effectively diagnoses the entire Cupressaceae pectate-lyase sensitization pattern in a single component.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.